痛風は、関節炎の一種で、特に足の親指の付け根の関節に腫れと激しい痛みを生じます。痛風は、血液中に尿酸がたまり、関節に炎症が起こることで発症します。症状としては、突然の関節痛、関節の腫れ、患部の熱感、関節の赤みなどがあります。危険因子としては、肥満、多量のアルコール摂取、関節の損傷、長年の腎臓病、プリン体を多く含む食品の多量摂取などが挙げられます。
目次
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Gouty Arthritis (Gout) - Overview
Gouty Arthritis (Gout) - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Gouty Arthritis (Gout) - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Gouty Arthritis (Gout) - Companies Involved in Therapeutics Development
Gouty Arthritis (Gout) - Drug Profiles
Gouty Arthritis (Gout) - Dormant Projects
Gouty Arthritis (Gout) - Discontinued Products
Gouty Arthritis (Gout) - Product Development Milestones
Featured News & Press Releases
Aug 09, 2022: Arthrosi completes AR882 renal impairment study
Aug 03, 2022: LG Chem enters final stage of clinical development for new gout drug
Jul 19, 2022: Allena pharmaceuticals announces completion of enrollment of cohorts A and B of ALLN-346 phase 2a study 202 in patients with Gout and stages 2 and 3 chronic kidney disease
Jun 16, 2022: Atom Bioscience to update clinical development of new drug to treat gout at BIO International Convention, June 13 - 16, 2022, San Diego, CA
Jun 13, 2022: Selecta Biosciences announces partnership advancements and clinical trial updates
Jun 02, 2022: Dyve Biosciences announces phase 2 TARGETS study of DYV702 for pain associated with acute gout flares showcased in podium presentation at 2022 EULAR congress
May 31, 2022: Fortress Biotech announces first patient dosed in phase 1 clinical trial evaluating dotinurad for the treatment of gout in the United States
Mar 21, 2022: Atom Bioscience announces positive phase 2a results for investigational new drug to treat chronic gout
Mar 15, 2022: The Phase I clinical trial of Eusen Jianheng's new gout drug UA007 was successfully completed
Dec 14, 2021: Arthrosi Therapeutics announces patient enrollment in global phase 2b study of AR882
Dec 02, 2021: Sobi and Selecta Biosciences complete enrolment for gout therapy trial
Nov 15, 2021: Dyve Biosciences hosting key opinion leader webinar on Gout and DYV702
Nov 08, 2021: Shanghai Fosun Pharmaceutical (Group) announcement in relation to the approval for Clinical Trial regarding Investigational New Drug of a subsidiary
Nov 03, 2021: Allena Pharmaceuticals receives Fast Track Designation from FDA for the Development of ALLN-346 for chronic treatment of hyperuricemia in patients with gout and advanced chronic kidney disease
Nov 02, 2021: Arthrosi presents AR882 posters at ACR 2021
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products under Development for Gouty Arthritis (Gout), 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Products under Development by Companies, 2022
Products under Development by Universities/Institutes, 2022
Number of Products by Stage and Target, 2022
Number of Products by Stage and Mechanism of Action, 2022
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Gouty Arthritis (Gout) - Dormant Projects, 2022
Gouty Arthritis (Gout) - Dormant Projects, 2022 (Contd..1)
Gouty Arthritis (Gout) - Dormant Projects, 2022 (Contd..2)
Gouty Arthritis (Gout) - Discontinued Products, 2022
List of Figures
Number of Products under Development for Gouty Arthritis (Gout), 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Number of Products by Top 10 Targets, 2022
Number of Products by Stage and Top 10 Targets, 2022
Number of Products by Top 10 Mechanism of Actions, 2022
Number of Products by Stage and Top 10 Mechanism of Actions, 2022
Number of Products by Top 10 Routes of Administration, 2022
Number of Products by Stage and Top 10 Routes of Administration, 2022
Number of Products by Top 10 Molecule Types, 2022
Number of Products by Stage and Top 10 Molecule Types, 2022
